Curasight (CURAS) | Spotlight

All marketplaces will be closed on December 24, 25, 26, and 31, as well as on January 1, 2026, due to public holidays

Curasight operates in the pharmaceutical industry. The company specializes in the development of technological products. The product portfolio has its main focus in the development of innovative technologies for the diagnosis and treatment of cancer based on targeted PET imaging and radionuclide therapy. The business is operated with the largest presence in Scandinavia. Curasight is headquartered in Copenhagen.

Quotes for Curasight A/S

Right Now

+/-: 0.3
%: 2,27%
Latest: 13.5
High: 13.9
Low: 13
Volume: 210 389
Turnover (DKK): 2 830 492
Market Value (MDKK): 619,2
Time (Latest trade)

Board

CEO

Ulrich Krasilnikoff

Chairperson of the Board

Kirsten Drejer

Board

Andreas Kjær
Charlotte Vedel
Lars Trolle
Ulrich Krasilnikoff

News

2025-12-18 17:19:17 Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT[®] in Brain Cancer
2025-12-14 17:34:00 Notice of Extraordinary General Meeting
2025-12-12 22:37:56 Curasight A/S has successfully completed a directed issue of shares of approximately DKK 16.4 million and has entered into a new loan facility
2025-12-12 18:38:58 Curasight A/S announces its intention to carry out a directed issue of shares and enter into a new loan facility
2025-11-28 11:09:28 Curasight to present at HC Andersen Capital

News agencies

2025-12-18 17:28:17 Finwire: Curasight doses first patient in Phase 1 study for brain tumor treatment
2025-12-18 17:26:31 Finwire: Curasight doserar första patienten i fas 1-studie för hjärntumörbehandling
2025-12-15 11:19:20 Finwire: Curasight raises over 16 million Danish kroner via directed new share issue, the discount was 20 percent
2025-12-15 06:41:44 Finwire: Curasight tar in över 16 miljoner danska kronor via riktad nyemission, rabatten blev 20 procent
2025-11-27 07:14:50 Finwire: Curasight rapporterar ökad rörelseförlust

Analysis

Videos

Largest Owners

Name	Capital %	Votes %	Date
Curium International Trading B.V	19,60	19,60	2025-08-04
Andreas Kjær	15,96	15,96	2025-08-04
UK Curacap ApS	11,62	11,62	2025-08-04
Carsten Haagen Nielsen	5,25	5,25	2025-08-04
Pentwater Capital Management LP	5,18	5,18	2025-08-04
Nordnet Bank AB	2,06	2,06	2025-08-04
Jacob Madsen	2,04	2,04	2025-08-04
Avanza Bank AB	1,58	1,58	2025-08-04
Chr. Olesen Holding A/S	1,54	1,54	2025-08-04
Lars Trolle	1,29	1,29	2025-09-01

Insider trading

*Powered by Modular Finance

Key Numbers

*Compiled data from Millistream

Upcoming reports

2025-12-29 Extraordinary General Meeting 2025
2026-02-26 Year End Report 2025
2026-04-23 Interim Report 2026-Q1
2026-08-27 Interim Report 2026-Q2
2026-11-26 Interim Report 2026-Q3

Curasight A/S